Institute For Follicular Lymphoma Innovation
- Assets
- $8.4m
- Revenue
- $11.5m
- Investments
- $0.0
- Employees
- 0
- Location
- Diamond Bar, CA
- Founding
- Data as of
- 12/2022
- EIN
- 88-0639274
Organization Overview
Institute For Follicular Lymphoma Innovation is located in Diamond Bar, CA. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Institute For Follicular Lymphoma Innovation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
PDF Copies of 990 Filings
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Andrew Peykoff II President/director | 1 | $0 | |
Kent Ratzlaff Secretary/director | 1 | $0 | |
David Mccullagh Cfo/director | 15 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $11,465,000 |
| Interest on Savings | $0 |
| Dividends & Interest | $0 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $0 |
| Capital Gain Net Income | $0 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $0 |
| Total Revenue | $11,465,000 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $0 |
| Other employee salaries and wages | $0 |
| Pension plans, employee benefits | $0 |
| Interest | $0 |
| Taxes | $0 |
| Depreciation | $0 |
| Occupancy | $0 |
| Travel, conferences, and meetings | $4,003 |
| Printing and publications | $0 |
| Other expenses | $290,521 |
| Total operating and administrative expenses | $1,688,572 |
| Contributions, gifts, grants paid | $1,453,863 |
| Total expenses and disbursements | $3,142,435 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $7,664,874 |
| Savings and temporary cash investments | $0 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $0 |
| Net Land, buildings, and equipment | $0 |
| Other assets | $763,698 |
| Total assets | $8,428,572 |
| Accounts payable and accrued expenses | $97,589 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $97,589 |
Grants Awarded
Over the last fiscal year, Institute For Follicular Lymphoma Innovation has awarded $3,525,042 in support to 9 organizations.
| Grant Recipient | Amount |
|---|---|
LYSARC PURPOSE: FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | $514,538 |
THE LEUKEMIA & LYMPHOMA SOCIETY INC PURPOSE: FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | $125,000 |
WASHINGTON UNIVERSITY PURPOSE: FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | $264,325 |
MAYO CLINIC PURPOSE: FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | $275,000 |
UNIVERSITY OF MIAMI PURPOSE: FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | $275,000 |
THE LEUKEMIA & LYMPHOMA SOCIETY INC PURPOSE: FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | $500,000 |